Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin irritation / corrosion

Currently viewing:

Administrative data

Endpoint:
skin irritation: in vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2008
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2008
Report date:
2008

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
EPA OPPTS 870.2500 (Acute Dermal Irritation)
GLP compliance:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
Decan-1-ol
EC Number:
203-956-9
EC Name:
Decan-1-ol
Cas Number:
112-30-1
Molecular formula:
C10H22O
IUPAC Name:
decan-1-ol
Test material form:
liquid

Test animals

Species:
rabbit
Strain:
New Zealand White
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Robinson Services Inc., Clemmons, NC
- Age at study initiation: young adults
- Housing: individually suspended stainless steel caging with mesh floors
- Diet: Purina rabbit chow, ad libitum
- Water: filtered tap water, ad libitum
- Acclimation period: 13 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-21
- Humidity (%): 55-83
- Photoperiod (hrs dark / hrs light): 12/12

Test system

Type of coverage:
semiocclusive
Preparation of test site:
shaved
Vehicle:
unchanged (no vehicle)
Controls:
no
Amount / concentration applied:
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 0.2ml
- Concentration (if solution): undiluted

Duration of treatment / exposure:
4 hours
Observation period:
The individual dose sites were scored at ca. 30-60 minutes, 24,48 and 72 hours and at 7 and 10 days after patch removal.
Number of animals:
3F
Details on study design:
TEST SITE
- Area of exposure: the back

- Type of wrap if used: The pad and the entire trunk of each animal were wrapped with semi-occlusive tape.

REMOVAL OF TEST SUBSTANCE
- Washing (if done):the test sites were gently cleansed with acetone, ethanol and a 3% soap solution followed by tap water using a clean paper towel to remove any residual test substance
- Time after start of exposure: 4 hours

SCORING SYSTEM: Draize

Results and discussion

In vivo

Resultsopen allclose all
Irritation parameter:
primary dermal irritation index (PDII)
Basis:
other:
Time point:
other: PDI for 30-60 minutes,24,48 and 72 hours/4
Score:
2.8
Irritation parameter:
erythema score
Basis:
animal #1
Time point:
24/48/72 h
Score:
1.66
Max. score:
4
Reversibility:
fully reversible within: 10 days
Irritation parameter:
erythema score
Basis:
animal #2
Time point:
24/48/72 h
Score:
1.66
Max. score:
4
Reversibility:
fully reversible within: 10 days
Irritation parameter:
erythema score
Basis:
animal #3
Time point:
24/48/72 h
Score:
1.33
Max. score:
4
Reversibility:
fully reversible within: 10 days
Irritation parameter:
edema score
Basis:
animal #1
Time point:
24/48/72 h
Score:
1
Max. score:
4
Reversibility:
fully reversible within: 10 days
Irritation parameter:
edema score
Basis:
animal #2
Time point:
24/48/72 h
Score:
1
Max. score:
4
Reversibility:
fully reversible within: 10 days
Irritation parameter:
edema score
Basis:
animal #3
Time point:
24/48/72 h
Score:
1
Max. score:
4
Reversibility:
fully reversible within: 10 days
Irritant / corrosive response data:
For the first 24 hours after patch removal, all three treated sites exhibited well-defined erythema and very slight edema. The overall incidence and severity of irritation decreased gradually with time. All animals were free of dermal irritation by day 10 (study termination).
Other effects:
All animals appeared active and healthy during the study. Apart from the dermal irritation noted, there were no signs of gross toxicity, adverse pharmacologic effects or abnormal behaviour.

Applicant's summary and conclusion

Interpretation of results:
Category 3 (mild irritant) based on GHS criteria
Remarks:
Not classified according to Regulation (EC) No 1272/2008
Conclusions:
The in vivo skin irritation study for decan-1-ol, conducted according to a protocol similar to OECD Test Guideline 404 and in compliance with GLP, concluded decan-1-ol to be mildly irritating to skin, but not sufficient for classification.